Ingersoll Rand Inc.

This synthesis is limited by what is on file. No Beneish M-Score, Piotroski F-Score, Altman Z-Score, or Fog Index is available for Ingersoll Rand in the data provided, so this analysis does not interpret any forensic screen and does not treat the absence of a score as either a pass or a fail. These screens are screening tools rather than conclusions, so a full read of the filings is needed before a view is formed. On the reported numbers alone, the revenue series shows steady growth over the three most recent fiscal years in the data: $6.88 billion in 2023, $7.24 billion in 2024, and $7.65 billion in 2025. Over the longer series, revenue was $2.69 billion in 2018, fell to $2.45 billion in 2019, and then rose to $4.91 billion in 2020, a step change the data does not explain. Operating income moved from $85.7 million in 2020 to $565.7 million in 2021, $817.3 million in 2022, $1.16 billion in 2023, and $1.3 billion in 2024 before declining to $1.14 billion in 2025. The 2025 decline is the first drop in operating income in the series since 2020, and it arrives alongside higher revenue, which is the pattern a careful reader would want to explain using the MD&A. Without segment data, product names, debt instruments, or legal matters in the provided text, this analysis cannot name which businesses drove the change. Readers may want to look at the MD&A discussion of segment results, the debt footnotes for interest obligations, and the legal proceedings section for items that could affect future earnings. The absence of risk-factor text also means this synthesis cannot compare management's own risk disclosures against the numbers, which is a core step in the analysis.

Catalyst.The data provided shows a revenue trend rather than the reasons behind it. Revenues rose from $6.88 billion in 2023 to $7.24 billion in 2024 and $7.65 billion in 2025, year-over-year increases of about 5.2% and 5.7%. Operating income reached $1.3 billion in 2024 before falling to $1.14 billion in 2025. No MD&A text is on file, so this synthesis cannot attribute the revenue growth to specific segments, products, pricing, or acquisitions.

Hidden risk.The most visible tension in the data is margin compression. Operating income fell about 12.3% in 2025, from $1.3 billion to $1.14 billion, while revenue grew about 5.7%. Operating margin, calculated as operating income divided by revenue, moved from roughly 18.0% in 2024 to roughly 14.9% in 2025. The data does not explain the cause, and no risk-factor text is on file to show whether management has flagged it. Readers may want to look at the risk factors and MD&A in the full annual report to see what management says about costs and margins.